FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 163 filers reported holding FIBROGEN INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393 | -93.2% | 1,616 | -78.1% | 0.00% | – |
| Q2 2023 | $20,414 | -84.3% | 7,369 | +8.0% | 0.00% | – |
| Q1 2023 | $130,015 | -5.8% | 6,825 | -21.4% | 0.00% | – |
| Q4 2022 | $138,000 | +24.3% | 8,682 | +1.7% | 0.00% | – |
| Q3 2022 | $111,000 | +15.6% | 8,539 | -1.2% | 0.00% | – |
| Q2 2022 | $96,000 | +128.6% | 8,639 | +0.6% | 0.00% | – |
| Q1 2022 | $42,000 | -67.7% | 8,588 | -3.6% | 0.00% | – |
| Q4 2021 | $130,000 | +176.6% | 8,909 | +90.6% | 0.00% | – |
| Q3 2021 | $47,000 | -78.5% | 4,673 | -43.2% | 0.00% | – |
| Q2 2021 | $219,000 | -33.8% | 8,232 | -12.2% | 0.00% | -100.0% |
| Q1 2021 | $331,000 | -1.8% | 9,380 | +3.2% | 0.00% | 0.0% |
| Q4 2020 | $337,000 | +44.6% | 9,093 | +59.5% | 0.00% | 0.0% |
| Q3 2020 | $233,000 | +17.7% | 5,701 | +17.0% | 0.00% | 0.0% |
| Q2 2020 | $198,000 | +21.5% | 4,871 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $163,000 | – | 4,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |